Functional variants in NBS1 and cancer risk: Evidence from a meta-analysis of 60 publications with 111 individual studies

Mutagenesis

Volumn 28, Issue 6, 2013, Pages 683-697

  Gao, Ping ^a   Ma, Ning ^a   Li, Man ^a   Tian, Qing Bao ^a   Liu, Dian Wu ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NIBRIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BASAL CELL CARCINOMA; BLADDER CANCER; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; COLON CANCER; COLORECTAL CANCER; DISEASE COURSE; EMBASE; ESOPHAGUS CANCER; ETHNICITY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC VARIABILITY; GENOTYPE; HUMAN; KIDNEY CARCINOMA; LARYNX CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MEDLINE; MEDULLOBLASTOMA; META ANALYSIS; NASOPHARYNX CARCINOMA; OROPHARYNX CANCER; OVARY CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; SYSTEMATIC REVIEW; THYROID CANCER;

CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MULTIVARIATE ANALYSIS; MUTATION, MISSENSE; NEOPLASMS; NUCLEAR PROTEINS; PENETRANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84888599972     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/get048     Document Type: Article

References (100)

1. Khanna, K. K. and Jackson, S. P. (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet., 27, 247-254.
2. Dasika, G. K., Lin, S. C., Zhao, S., Sung, P., Tomkinson, A. and Lee, E. Y. (1999) DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene, 18, 7883-7899.
3. Ferguson, D. O. and Alt, F. W. (2001) DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene, 20, 5572-5579.
4. Zhang, Y., Zhou, J. and Lim, C. U. (2006) The role of NBS1 in DNA double strand break repair, telomere stability, and cell cycle checkpoint control. Cell Res., 16, 45-54.
5. Millikan, R. C., Player, J. S., Decotret, A. R., Tse, C. K. and Keku, T. (2005) Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 14, 2326-2334.
6. Thirumaran, R. K., Bermejo, J. L., Rudnai, P., et al. (2006) Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis, 27, 1676-1681.
7. Zienolddiny, S., Campa, D., Lind, H., Ryberg, D., Skaug, V., Stangeland, L., Phillips, D. H., Canzian, F. and Haugen, A. (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis, 27, 560-567.
8. Lu, M., Lu, J., Yang, X., Yang, M., Tan, H., Yun, B. and Shi, L. (2009) Association between the NBS1 E185Q polymorphism and cancer risk: A meta-analysis. BMC Cancer, 9, 124.
9. Yao, F., Fang, Y., Chen, B., Jin, F. and Wang, S. (2013) Association between the NBS1 Glu185Gln polymorphism and breast cancer risk: A meta-analysis. Tumour Biol., 34, 1255-1262.
10. Thakkinstian, A., McElduff, P., D'Este, C., Duffy, D. and Attia, J. (2005) A method for meta-analysis of molecular association studies. Stat. Med., 24, 1291-1306.
11. Minelli, C., Thompson, J. R., Abrams, K. R., Thakkinstian, A. and Attia, J. (2005) The choice of a genetic model in the meta-analysis of molecular association studies. Int. J. Epidemiol., 34, 1319-1328.
12. Egger, M., Davey Smith, G., Schneider, M. and Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-634.
13. Popanda, O., Tan, X. L., Ambrosone, C. B., et al. (2006) Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients. Cancer Epidemiol. Biomarkers Prev., 15, 1048-1050.
14. Stanulla, M., Stumm, M., Dieckvoss, B. O., Seidemann, K., Schemmel, V., Muller Brechlin, A., Schrappe, M., Welte, K. and Reiter, A. (2000) No evidence for a major role of heterozygous deletion 657del5 within the NBS1 gene in the pathogenesis of non-Hodgkin's lymphoma of childhood and adolescence. Br. J. Haematol., 109, 117-120.
15. Sokolenko, A. P., Rozanov, M. E., Mitiushkina, N. V., et al. (2007) Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia. Fam. Cancer, 6, 281-286.
16. Huang, J., Grotzer, M. A., Watanabe, T., Hewer, E., Pietsch, T., Rutkowski, S. and Ohgaki, H. (2008) Mutations in the Nijmegen breakage syndrome gene in medulloblastomas. Clin. Cancer Res., 14, 4053-4058.
17. Ziołkowska, I., Mosor, M. and Nowak, J. (2006) Regional distribution of heterozygous 657del5 mutation carriers of the NBS1 gene in Wielkopolska province (Poland). J. Appl. Genet., 47, 269-272.
18. Seemanova, E., Jarolim, P., Seeman, P., Varon, R., Digweed, M., Swift, M. and Sperling, K. (2007) Cancer risk of heterozygotes with the NBN founder mutation. J. Natl Cancer Inst., 99, 1875-1880.
19. Hama, S., Matsuura, S., Tauchi, H., et al. (2000) Absence of mutations in the NBS1 gene in B-cell malignant lymphoma patients. Anticancer Res., 20, 1897-1900.
20. Medina, P. P., Ahrendt, S. A., Pollan, M., Fernandez, P., Sidransky, D. and Sanchez-Cespedes, M. (2003) Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations. Cancer Epidemiol. Biomarkers Prev., 12, 699-704.
21. Mohrenweiser, H. W., Xi, T., Vazquez-Matias, J. and Jones, I. M. (2002) Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol. Biomarkers Prev., 11, 1054-1064.
22. Rischewski, J., Bismarck, P., Kabisch, H., Janka-Schaub, G., Obser, T. and Schneppenheim, R. (2000) The common deletion 657del5 in the Nibrin gene is not a major risk factor for B or T cell non-Hodgkin lymphoma in a pediatric population. Leukemia, 14, 1528-1529.
23. Cao, A. Y., Hu, Z., Yin, W. J., Jin, W. and Shao, Z. M. (2010) Some common mutations of RAD50 and NBS1 in western populations do not contribute significantly to Chinese non-BRCA1/2 hereditary breast cancer. Breast Cancer Res. Treat., 121, 247-249.
24. Schuetz, J. M., MaCarthur, A. C., Leach, S., Lai, A. S., Gallagher, R. P., Connors, J. M., Gascoyne, R. D., Spinelli, J. J. and Brooks-Wilson, A. R. (2009) Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma. BMC Med. Genet., 10, 117.
25. Heikkinen, K., Rapakko, K., Karppinen, S. M., et al. (2006) RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis, 27, 1593-1599.
26. Yang, L., Li, Y., Cheng, M., et al. (2012) A functional polymorphism at microRNA-629-binding site in the 3'-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. Carcinogenesis, 33, 338-347.
27. Huang, M. D., Chen, X. F., Xu, G., Wu, Q. Q., Zhang, J. H., Chen, G. F., Cai, Y. and Qi, F. Z. (2012) Genetic variation in the NBS1 gene is associated with hepatic cancer risk in a Chinese population. DNA Cell Biol., 31, 678-682.
28. Zheng, J., Zhang, C., Jiang, L., You, Y., Liu, Y., Lu, J. and Zhou, Y. (2011) Functional NBS1 polymorphism is associated with occurrence and advanced disease status of nasopharyngeal carcinoma. Mol. Carcinog., 50, 689-696.
29. Gil, J., Ramsey, D., Stembalska, A., Karpinski, P., Pesz, K. A., Laczmanska, I., Leszczynski, P., Grzebieniak, Z. and Sasiadek, M. M. (2012) The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. Mol. Biol. Rep., 39, 527-534.
30. Jiang, L., Liang, J., Jiang, M., Yu, X., Zheng, J., Liu, H., Wu, D. and Zhou, Y. (2011) Functional polymorphisms in the NBS1 gene and acute lymphoblastic leukemia susceptibility in a Chinese population. Eur. J. Haematol., 86, 199-205.
31. Jelonek, K., Gdowicz-Klosok, A., Pietrowska, M., Borkowska, M., Korfanty, J., Rzeszowska-Wolny, J. and Widlak, P. (2010) Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J. Appl. Genet., 51, 343-352.
32. Park, S. L., Bastani, D., Goldstein, B. Y., et al. (2010) Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers. Carcinogenesis, 31, 1264-1271.
33. Silva, S. N., Tomar, M., Paulo, C., Gomes, B. C., Azevedo, A. P., Teixeira, V., Pina, J. E., Rueff, J. and Gaspar, J. F. (2010) Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiol., 34, 85-92.
34. Ciara, E., Piekutowska-Abramczuk, D., Popowska, E., et al. (2010) Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients. Acta Neuropathol., 119, 325-334.
35. Bastos, H. N., Antao, M. R., Silva, S. N., et al. (2009) Association of polymorphisms in genes of the homologous recombination DNA repair pathway and thyroid cancer risk. Thyroid, 19, 1067-1075.
36. Loizidou, M. A., Cariolou, M. A., Neuhausen, S. L., et al. (2010) Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population. Breast Cancer Res. Treat., 121, 147-156.
37. Desjardins, S., Beauparlant, J. C., Labrie, Y., Ouellette, G. and Durocher, F.; INHERIT BRCAs. (2009) Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer. BMC Cancer, 9, 181.
38. Margulis, V., Lin, J., Yang, H., Wang, W., Wood, C. G. and Wu, X. (2008) Genetic susceptibility to renal cell carcinoma: The role of DNA doublestrand break repair pathway. Cancer Epidemiol. Biomarkers Prev., 17, 2366-2373.
39. Smith, T. R., Levine, E. A., Freimanis, R. I., Akman, S. A., Allen, G. O., Hoang, K. N., Liu-Mares, W. and Hu, J. J. (2008) Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis, 29, 2132-2138.
40. Choudhury, A., Elliott, F., Iles, M. M., Churchman, M., Bristow, R. G., Bishop, D. T. and Kiltie, A. E. (2008) Analysis of variants in DNA damage signalling genes in bladder cancer. BMC Med. Genet., 9, 69.
41. Roznowski, K., Januszkiewicz-Lewandowska, D., Mosor, M., Pernak, M., Litwiniuk, M. and Nowak, J. (2008) I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer. Breast Cancer Res. Treat., 110, 343-348.
42. Ziolkowska, I., Mosor, M., Wierzbicka, M., Rydzanicz, M., Pernak- Schwarz, M. and Nowak, J. (2007) Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Cancer Sci., 98, 1701-1705.
43. Figueroa, J. D., Malats, N., Rothman, N., et al. (2007) Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis, 28, 1788-1793.
44. Lu, J., Wei, Q., Bondy, M. L., et al. (2006) Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non- Hispanic white women
45. Hebbring, S. J., Fredriksson, H., White, K. A., et al. (2006) Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer. Cancer Epidemiol. Biomarkers Prev., 15, 935-938.
46. Zhang, L., Zhang, Z. and Yan, W. (2005) Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin. Chim. Acta., 359, 150-155.
47. Auranen, A., Song, H., Waterfall, C., et al. (2005) Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Int. J. Cancer, 117, 611-618.
48. Lan, Q., Shen, M., Berndt, S. I., et al. (2005) Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China. Lung Cancer, 49, 317-323.
49. Festa, F., Kumar, R., Sanyal, S., et al. (2005) Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and iron metabolism. Mutat. Res., 574, 105-111.
50. Sanyal, S., Festa, F., Sakano, S., et al. (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis, 25, 729-734.
51. Kuschel, B., Auranen, A., McBride, S., et al. (2002) Variants in DNA double- strand break repair genes and breast cancer susceptibility. Hum. Mol. Genet., 11, 1399-1407.
52. Bogdanova, N., Feshchenko, S., Schurmann, P., et al. (2008) Nijmegen Breakage Syndrome mutations and risk of breast cancer. Int. J. Cancer, 122, 802-806.
53. Steffen, J., Nowakowska, D., Niwinska, A., Czapczak, D., Kluska, A., Piatkowska, M., Wisniewska, A. and Paszko, Z. (2006) Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. Int. J. Cancer, 119, 472-475.
54. Steffen, J., Varon, R., Mosor, M., et al. (2004) Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int. J. Cancer, 111, 67-71.
55. Gorski, B., Debniak, T., Masojć, B., et al. (2003) Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int. J. Cancer, 106, 379-381.
56. Gorski, B., Cybulski, C., Huzarski, T., et al. (2005) Breast cancer predisposing alleles in Poland. Breast Cancer Res. Treat., 92, 19-24.
57. Buslov, K. G., Iyevleva, A. G., Chekmariova, E. V., et al. (2005) NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. Int. J. Cancer, 114, 585-589.
58. Carlomagno, F., Chang-Claude, J., Dunning, A. M. and Ponder, B. A. (1999) Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer. Genes. Chromosomes Cancer, 25, 393-395.
59. Bogdanova, N., Schurmann, P., Waltes, R., Feshchenko, S., Zalutsky, I. V., Bremer, M. and Dork, T. (2008) NBS1 variant I171V and breast cancer risk. Breast Cancer Res. Treat., 112, 75-79.
60. Broberg, K., Bjork, J., Paulsson, K., Hoglund, M. and Albin, M. (2005) Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis, 26, 1263-1271.
61. Pardini, B., Naccarati, A., Novotny, J., et al. (2008) DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat. Res. 638, 146-153.
62. Li, N., Xu, Y., Zheng, J., Jiang, L., You, Y., Wu, H., Li, W., Wu, D. and Zhou, Y. (2013) NBS1 rs1805794G>C polymorphism is associated with decreased risk of acute myeloid leukemia in a Chinese population. Mol. Biol. Rep., 40, 3749-3756.
63. Wu, X., Gu, J., Grossman, H. B., et al. (2006) Bladder cancer predisposition: A multigenic approach to DNA-repair and cell-cycle-control genes. Am. J. Hum. Genet., 78, 464-479.
64. Chrzanowska, K. H., Piekutowska-Abramczuk, D., Popowska, E., et al. (2006) Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies. Int. J. Cancer, 118, 1269-1274.
65. Soucek, P., Gut, I., Trneny, M., Skovlund, E., Grenaker Alnaes, G., Kristensen, T., Borresen-Dale, A. L. and Kristensen, V. N. (2003) Multiplex single-tube screening for mutations in the Nijmegen Breakage Syndrome (NBS1) gene in Hodgkin's and non-Hodgkin's lymphoma patients of Slavic origin. Eur. J. Hum. Genet., 11, 416-419.
66. Resnick, I. B., Kondratenko, I., Pashanov, E., et al. (2003) 657del5 mutation in the gene for Nijmegen breakage syndrome (NBS1) in a cohort of Russian children with lymphoid tissue malignancies and controls. Am. J. Med. Genet. A, 120A, 174-179.
67. Mosor, M., Ziołkowska, I., Pernak-Schwarz, M., Januszkiewicz- Lewandowska, D. and Nowak, J. (2006) Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia. Leukemia, 20, 1454-1456.
68. Rollinson, S., Kesby, H. and Morgan, G. J. (2006) Haplotypic variation in MRE11, RAD50 and NBS1 and risk of non-Hodgkin's lymphoma. Leuk. Lymphoma, 47, 2567-2583.
69. Varon, R., Reis, A., Henze, G., von Einsiedel, H. G., Sperling, K. and Seeger, K. (2001) Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL). Cancer Res., 61, 3570-3572.
70. Cybulski, C., Gorski, B., Debniak, T., et al. (2004) NBS1 is a prostate cancer susceptibility gene. Cancer Res., 64, 1215-1219.
71. Kanka, C., Brozek, I., Skalska, B., Siemiatkowska, A. and Limon, J. (2007) Germline NBS1 mutations in families with aggregation of breast and/or ovarian cancer from north-east Poland. Anticancer Res 27, 3015-3018.
72. Nowak, J., Mosor, M., Ziołkowska, I., et al. (2008) Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours. Eur. J. Cancer, 44, 627-630.
73. Piekutowska-Abramczuk, D., Ciara, E., Popowska, E., et al. (2010) The frequency of NBN molecular variants in pediatric astrocytic tumors. J. Neurooncol., 96, 161-168.
74. Han, J., Haiman, C., Niu, T., Guo, Q., Cox, D. G., Willett, W. C., Hankinson, S. E. and Hunter, D. J. (2009) Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk. Breast Cancer Res. Treat., 115, 613-622.
75. Teo, M. T., Landi, D., Taylor, C. F., et al. (2012) The role of microRNAbinding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis, 33, 581-586.
76. Debniak, T., Gorski, B., Cybulski, C., et al. (2003) Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin. Melanoma Res., 13, 365-370.
77. Steffen, J., Maneva, G., Popławska, L., Varon, R., Mioduszewska, O. and Sperling, K. (2006) Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation. Int. J. Cancer, 119, 2970-2973.
78. Mosor, M., Ziołkowska, I., Januszkiewicz-Lewandowska, D. and Nowak, J. (2008) Polymorphisms and haplotypes of the NBS1 gene in childhood acute leukaemia. Eur. J. Cancer, 44, 2226-2232.
79. Mateju, M., Kleiblova, P., Kleibl, Z., Janatova, M., Soukupova, J., Ticha, I., Novotny, J. and Pohlreich, P. (2012) Germline mutations 657del5 and 643C>T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women. Breast Cancer Res. Treat., 133, 809-811.
80. Huang, J., Zhao, Y., Li, Q., Zhang, J., Wang, Y. and Zhang, B. (2012) Association of single nucleotide polymorphisms of NBS1 gene with genetic susceptibility to primary liver cancer in a Chinese Han Population. Prog. Biochem. Biophys., 39, 678-686.
81. Qiu, Y., Lin, Y., Huang, M., Chen, X., He, F., Fan, L., Chen, B. and Cai, L. (2011) Association of smoking, residential environment and polymorphisms with lung cancer. J. Environ. Occup. Med. 28, 133-136-140.
82. Fan, L. H., Chen, J. L. and Cai, L. (2010) [Study on the association between DNA double-strand break repair gene NBS1 polymorphisms and susceptibility on lung cancer]. Zhonghua Liu Xing Bing Xue Za Zhi, 31, 213-217.
83. Attia, J., Thakkinstian, A. and D'Este, C. (2003) Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J. Clin. Epidemiol., 56, 297-303.
84. Bender, R. and Lange, S. (2001) Adjusting for multiple testing-when and how? J. Clin. Epidemiol., 54, 343-349.
85. Bland, J. M. and Altman, D. G. (1995) Multiple significance tests: The Bonferroni method. BMJ, 310, 170.
86. Sankoh, A. J., Huque, M. F. and Dubey, S. D. (1997) Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat. Med., 16, 2529-2542.
87. Kruger, L., Demuth, I., Neitzel, H., Varon, R., Sperling, K., Chrzanowska, K. H., Seemanova, E. and Digweed, M. (2007) Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein. Carcinogenesis, 28, 107-111.
88. Kinzler, K. W. and Vogelstein, B. (1997) Cancer-susceptibility genes. Gatekeepers and caretakers. Nature, 386, 761, 763.
89. Kang, J., Ferguson, D., Song, H., Bassing, C., Eckersdorff, M., Alt, F. W. and Xu, Y. (2005) Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Mol. Cell. Biol., 25, 661-670.
90. Dumon-Jones, V., Frappart, P. O., Tong, W. M., Sajithlal, G., Hulla, W., Schmid, G., Herceg, Z., Digweed, M. and Wang, Z. Q. (2003) Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis. Cancer Res., 63, 7263-7269.
91. Difilippantonio, S., Celeste, A., Fernandez-Capetillo, O., et al. (2005) Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat. Cell Biol., 7, 675-685.
92. Zhang, Z. H., Yang, L. S., Huang, F., Hao, J. H., Su, P. Y. and Sun, Y. H. (2012) Current evidence on the relationship between two polymorphisms in the NBS1 gene and breast cancer risk: A meta-analysis. Asian Pac. J. Cancer Prev., 13, 5375-5379.
93. di Masi, A., Viganotti, M., Polticelli, F., Ascenzi, P., Tanzarella, C. and Antoccia, A. (2008) The R215W mutation in NBS1 impairs gamma- H2AX binding and affects DNA repair: molecular bases for the severe phenotype of 657del5/R215W Nijmegen breakage syndrome patients. Biochem. Biophys. Res. Commun., 369, 835-840.
94. Comings, D. E. and MacMurray, J. P. (2000) Molecular heterosis: A review. Mol. Genet. Metab., 71, 19-31.
95. Salinas-Sanchez, A. S., Donate-Moreno, M. J., Lopez-Garrido, M. P., Gimenez-Bachs, J. M. and Escribano, J. (2012) Role of CYP1B1 gene polymorphisms in bladder cancer susceptibility. J. Urol.187, 700-706.
96. Yager, J. D. (2000) Endogenous estrogens as carcinogens through metabolic activation. J. Natl Cancer Inst., 27, 67-73.
97. Hsu, H. M., Wang, H. C., Chen, S. T., Hsu, G. C., Shen, C. Y. and Yu, J. C. (2007) Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex. Cancer Epidemiol. Biomarkers Prev., 16, 2024-2032.
98. Sanchez-Cespedes, M., Ahrendt, S. A., Piantadosi, S., et al. (2001) Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res., 61, 1309-1313.
99. Haruki, N., Harano, T., Masuda, A., et al. (2001) Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation. Am. J. Pathol., 159, 1345-1352.
100. Thompson, S. G. (1994) Why sources of heterogeneity in meta-analysis should be investigated. BMJ, 309, 1351-1355.